Interferon-α therapy – which patients will develop depression?

被引:0
|
作者
机构
关键词
Public Health; Melanoma; Interferon; Psychiatric Disorder; England Journal;
D O I
10.2165/00128415-199907500-00008
中图分类号
学科分类号
摘要
引用
收藏
页码:4 / 4
相关论文
共 50 条
  • [21] Risk factors for the development of depression in patients with hepatitis C taking interferon-α
    Smith, Kimberley J.
    Norris, Suzanne
    O'Farrelly, Cliona
    O'Mara, Shane M.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 275 - 292
  • [22] Side Effects of Interferon-α Therapy
    Stefan Sleijfer
    Marjolein Bannink
    Arthur R. Van Gool
    Wim H. J. Kruit
    Gerrit Stoter
    Pharmacy World and Science, 2005, 27 : 423 - 431
  • [23] Sorafenib:: combination therapy with Interferon-α
    Roigas, J.
    ONKOLOGE, 2007, 13 : 19 - 20
  • [24] HLA-alleles determine the risk to develop antibodies against interferon-β therapy in multiple sclerosis
    Buck, D.
    Cepok, S.
    Hoffmann, S.
    Grummel, V.
    Lehmann-Horn, K.
    Hackermueller, J.
    Stadler, P. F.
    Hartung, H. P.
    Berthele, A.
    Deisenhammer, F.
    Wassmuth, R.
    Hemmer, B.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S183 - S183
  • [25] Thyrotoxicosis after interferon-α therapy
    Csaki, AC
    Blum, M
    THYROID, 2000, 10 (01) : 101 - 101
  • [26] Interferon-λ in HCV Infection and Therapy
    Pagliaccetti, Nicole E.
    Robek, Michael D.
    VIRUSES-BASEL, 2010, 2 (08): : 1589 - 1602
  • [27] Side effects of interferon-α therapy
    Sleijfer, S
    Bannink, M
    Van Gool, AR
    Kruit, WHJ
    Stoter, G
    PHARMACY WORLD & SCIENCE, 2005, 27 (06): : 423 - 431
  • [28] Kaposiform hemangioendothelioma and therapy with interferon-α
    Deb, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (06): : 593 - 593
  • [29] Injecting rationale into interferon-β therapy
    Reder, AT
    Antel, JP
    NEUROLOGY, 2000, 54 (11) : 2034 - 2035
  • [30] Safety profile of interferon-α therapy
    Weiss, K
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 9 - 13